Thermosensitive Exosome–Liposome Hybrid Nanoparticle‐Mediated Chemoimmunotherapy for Improved Treatment of Metastatic Peritoneal Cancer

Thermosensitive Exosome–Liposome Hybrid Nanoparticle‐Mediated Chemoimmunotherapy for Improved Treatment of Metastatic Peritoneal Cancer

Abstract Metastatic peritoneal carcinoma (mPC) is a deadly disease without effective treatment. To improve treatment of this disease, a recently developed hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as the standard of care. However, the efficacy of this approach is limited by ineff...

Full description

Bibliographic Details
Main Authors: Qijun Lv, Lili Cheng, Yao Lu, Xiaoge Zhang, Yizhen Wang, Junfeng Deng, Jiangbing Zhou, Bo Liu, Jie Liu
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Advanced Science
Subjects:
chemoimmunotherapy
exosomes
hyperthermic intraperitoneal chemotherapy
metastatic peritoneal carcinoma
thermosensitive liposomes
Online Access:https://doi.org/10.1002/advs.202000515

Similar Items

Similar Items